首页365bet娱乐官网网址365bet国际娱乐城365bet体育在线官电子期刊下载专区广告合作征稿启事留言板
位置:首页 >> 电子期刊 >> 正文
重组人血管内皮抑素联合肝动脉化疗栓塞治疗结直肠癌术后肝转移的临床应用
作者:贾中芝  李绍钦  田丰  赵进委  王凯  王云  蒋利强  蒋国民 
单位:南京医科大学附属常州第二人民医院介入科  江苏 常州 213003 
关键词:结直肠肿瘤/药物疗法 内皮抑素类/治疗应用 肝肿瘤/药物疗法 肝肿瘤/继发性 化学疗法 肿瘤 局部灌注 栓塞 治疗性 治疗结果 
DOI:R735.3+5;R735.3+7
出版年,卷(期):页码:2012,27(2):148-151
摘要:
目的 探讨重组人血管内皮抑素联合肝动脉化疗栓塞(TACE)治疗结直肠癌术后肝转移的临床疗效与安全性。方法 32例结直肠癌术后肝转移患者分为治疗组和对照组,治疗组采用重组人血管内皮抑素联合TACE治疗,对照组常规TACE治疗,两次治疗间隔1月。3周期后,按照RECIST标准评价疗效,观察Karnofsky评分(KPS)、CEA表达水平变化情况,对相关数据进行统计学分析。结果 两组术后均无CR患者,治疗组在治疗效果、K氏评分明显好于对照组,CEA表达水平与对照组比较差异均有统计学意义(P < 0.05)。不良反应与对照组比较差异无统计学意义(P > 0.05)。结论 重组人血管内皮抑素联合肝动脉化疗栓塞治疗结直肠癌术后肝转移可以改善患者K氏评分,提高治疗有效率及疾病控制率,且不良反应小,安全性好,长期结果有待进一步观察。
Objective To investigate the efficacy and safety of recombinant human endostatin combined with transcatheter arterial chemoembolization (TACE) in treatment of liver metastasis of colorectal cancer. Methods Thirty-two patients with liver metastasis of colorectal cancer were treated with recombinant human endostatin combined with TACE (trial group) or TACE alone (control group) with 16 cases in each group; the treatment was repeated in one month interval. After three therapeutic cycles, the clinical effect was evaluated with RECIST criteria, and the Karnofsky scoring, the plasma CEA levels were measured. Results There were no CR patients in both groups. The disease control rate and the Karnofsky scores were significantly higher in trial group than those in control group (P < 0.05) and there were significant differences in plasma CEA levels between two groups (P < 0.05). Adverse reactions were mild and there was no significant difference between two groups (P > 0.05). Conclusion Recombinant human endostatin combined with TACE can improve Karnofsky scores and disease control rate with few adverse effects for patients with liver metastasis of colorectal cancer.
文章下载】【加入收藏

浙ICP备18004413号

技术服务qq:1507079184(投稿系统问题可找我)

编辑部地址:浙江省杭州市上城区解放路88号(浙医二院内)

电话:0571-87783654 邮编:310009 E-mail:shyzhl@zju.edu.cn

期刊介绍 使用帮助 | 365bet体育在线官 | 留言板